Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients.
Cancer Commun (Lond)
; 43(7): 749-764, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37377402
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
Type of study:
Observational_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Cancer Commun (Lond)
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: